Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study

OBJECTIVES: To evaluate in a multicentric Italian cohort of patients with psoriatic arthritis (PsA) on secukinumab followed for 24 months: (1) the long-term effectiveness and safety of secukinumab, (2) the drug retention rate and minimal disease activity (MDA), (3) differences in the outcomes accordi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramonda, Roberta, Lorenzin, Mariagrazia, Carriero, Antonio, Chimenti, Maria Sole, Scarpa, Raffaele, Marchesoni, Antonio, Lubrano, Ennio, Salvarani, Carlo, Cauli, Alberto, Semeraro, Angelo, Santo, Leonardo, Ortolan, Augusta, Doria, Andrea, Fracassi, Elena, Virelli, Giulia, Masia, Marco, Fanizzi, Rosalinda, Visalli, Elisa, Amato, Giorgio, Carletto, Antonio, Foti, Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888309/
https://www.ncbi.nlm.nih.gov/pubmed/33593933
http://dx.doi.org/10.1136/rmdopen-2020-001519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888309/
https://www.ncbi.nlm.nih.gov/pubmed/33593933
http://dx.doi.org/10.1136/rmdopen-2020-001519

Ejemplares similares